Erik Magnus Ohman, MBBS

Professor of Medicine
Member in the Duke Clinical Research Institute
Campus mail 8678A Hafs Bldg, Durham, NC 27710
Phone (919) 681-2069
Email address ohman001@mc.duke.edu

Dr. Ohman, Professor of Medicine, received medical degrees from the Royal College of Surgeons in Ireland and the National University of Ireland (1984, Fellowship 1984-1987), and completed his training in cardiology at Duke University (1987-1991), where he has remained on faculty. In 2001, he became Chief of Cardiology at the University of North Carolina at Chapel Hill, where he founded the UNC Heart Center and became its first director. In 2005 he returned to Duke to pursue his interest in advanced coronary disease as the Director of the Program for Advanced Coronary Disease. Since that time, he has been appointed to Associate Director of the Duke Heart Center, the Kent and Siri Rawson Director for the Program for Advanced Coronary Disease, and most recently, Vice-Chair of Development and Innovation in the Department of Medicine.

Dr. Ohman’s clinical and research interests include interventional cardiology and high-risk supported PCI, and treatment of patients with advanced/complex coronary disease. He has researched how to improve patient care through the use of guidelines-based therapies and adherence, and examining global cardiovascular risk and health. He has been a participant on numerous guidelines writing committees, served on the ACC/AHA oversight committee for guidelines development, and has served on the steering committees for trials on ST-elevation myocardial infarction and non-ST-elevation ACS. He is a consultant to the National Institutes of Health, and a consultant for the FDA Advisory Panel for Cardiovascular Devices. 

Dr. Ohman has published over 600 peer-reviewed papers and three books in cardiovascular medicine. He holds three U.S. patents in reperfusion therapy. He is an associate editor for the American Heart Journal and serves on the editorial boards of the Journal of the American College of Cardiology and the American Journal of Cardiology.  He is a Fellow of the Royal College of Physicians in Ireland, the Royal Society of Medicine (U.K.), the European Society of Cardiology, the Society of Cardiac Angiography and Interventions, and the American College of Cardiology. 

Education and Training

  • M.B.B.S., Royal College of Surgeons (Ireland), 1981

Publications

Clemmensen, P., E. M. Ohman, D. C. Sevilla, T. Skelton, N. B. Wagner, P. S. Quigley, P. Grande, and G. S. Wagner. “Impact of infarct artery patency on the relationship between electrocardiographic and ventriculographic evidence of acute myocardial ischaemia..” Eur Heart J 15, no. 10 (October 1994): 1356–61. https://doi.org/10.1093/oxfordjournals.eurheartj.a060394.

PMID
7821312
Full Text

Ellis, S. G., A. M. Lincoff, B. S. George, D. J. Kereiakes, E. M. Ohman, M. W. Krucoff, R. M. Califf, and E. J. Topol. “Randomized evaluation of coronary angioplasty for early TIMI 2 flow after thrombolytic therapy for the treatment of acute myocardial infarction: A new look at an old study.” Coronary Artery Disease 5, no. 7 (September 13, 1994): 611–15.

Scholars@Duke

Ohman, E. M., B. S. George, C. J. White, M. J. Kern, P. A. Gurbel, R. J. Freedman, C. Lundergan, J. R. Hartmann, J. D. Talley, and M. J. Frey. “Use of aortic counterpulsation to improve sustained coronary artery patency during acute myocardial infarction. Results of a randomized trial. The Randomized IABP Study Group..” Circulation 90, no. 2 (August 1994): 792–99.

PMID
8044950
Scholars@Duke

Ellis, S. G., A. M. Lincoff, B. S. George, D. J. Kereiakes, E. M. Ohman, M. W. Krucoff, R. M. Califf, and E. J. Topol. “Randomized evaluation of coronary angioplasty for early TIMI 2 flow after thrombolytic therapy for the treatment of acute myocardial infarction: a new look at an old study. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group..” Coron Artery Dis 5, no. 7 (July 1994): 611–15.

PMID
7952423
Scholars@Duke

Hillegass, W. B., E. M. Ohman, J. D. Leimberger, and R. M. Califf. “A meta-analysis of randomized trials of calcium antagonists to reduce restenosis after coronary angioplasty..” Am J Cardiol 73, no. 12 (May 1, 1994): 835–39.

PMID
8184803
Scholars@Duke

Labinaz, M., S. G. Ellis, H. R. Phillips, and E. M. Ohman. “The role of angioplasty after successful thrombolysis for acute myocardial infarction..” Coron Artery Dis 5, no. 5 (May 1994): 399–406.

PMID
7921371
Scholars@Duke

Hillegass, W. B., J. G. Jollis, C. B. Granger, E. M. Ohman, R. M. Califf, and D. B. Mark. “Intracranial hemorrhage risk and new thrombolytic therapies in acute myocardial infarction..” Am J Cardiol 73, no. 7 (March 1, 1994): 444–49.

PMID
8141084
Scholars@Duke

Ohman, E. M., J. F. Marquis, D. R. Ricci, R. I. Brown, M. L. Knudtson, D. J. Kereiakes, J. K. Samaha, J. R. Margolis, A. L. Niederman, and L. S. Dean. “A randomized comparison of the effects of gradual prolonged versus standard primary balloon inflation on early and late outcome. Results of a multicenter clinical trial. Perfusion Balloon Catheter Study Group..” Circulation 89, no. 3 (March 1994): 1118–25.

PMID
8124798
Scholars@Duke

Ohman, E. M., E. J. Topol, R. M. Califf, E. R. Bates, S. G. Ellis, D. J. Kereiakes, B. S. George, J. K. Samaha, E. Kline, and K. N. Sigmon. “An analysis of the cause of early mortality after administration of thrombolytic therapy. The Thrombolysis Angioplasty in Myocardial Infarction Study Group..” Coron Artery Dis 4, no. 11 (November 1993): 957–64.

PMID
8173712
Scholars@Duke

Ohman, E. M., R. H. Christenson, R. M. Califf, B. S. George, J. K. Samaha, D. J. Kereiakes, S. J. Worley, T. C. Wall, E. Berrios, and K. N. Sigmon. “Noninvasive detection of reperfusion after thrombolysis based on serum creatine kinase MB changes and clinical variables. TAMI 7 Study Group. Thrombolysis and Angioplasty in Myocardial Infarction..” Am Heart J 126, no. 4 (October 1993): 819–26.

PMID
8213437
Scholars@Duke

Pages